New CGRP-targeted migraine drugs are offering safer, more effective relief for chronic sufferers by reducing headache days with fewer side effects. Unlike older treatments, these therapies are better tolerated and improve treatment adherence. While promising, experts stress the need for long-term studies and personalised care to determine the best option for managing migraines effectively.